Your browser doesn't support javascript.
loading
Infection with flaviviruses requires BCLXL for cell survival.
Suzuki, Tatsuya; Okamoto, Toru; Katoh, Hiroshi; Sugiyama, Yukari; Kusakabe, Shinji; Tokunaga, Makoto; Hirano, Junki; Miyata, Yuka; Fukuhara, Takasuke; Ikawa, Masahito; Satoh, Takashi; Yoshio, Sachiyo; Suzuki, Ryosuke; Saijo, Masayuki; Huang, David C S; Kanto, Tatsuya; Akira, Shizuo; Matsuura, Yoshiharu.
Afiliação
  • Suzuki T; Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
  • Okamoto T; Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
  • Katoh H; Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
  • Sugiyama Y; Department of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.
  • Kusakabe S; Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
  • Tokunaga M; Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
  • Hirano J; Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
  • Miyata Y; Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
  • Fukuhara T; Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
  • Ikawa M; Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
  • Satoh T; Department of Experimental Genome Research, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
  • Yoshio S; Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
  • Suzuki R; The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan.
  • Saijo M; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
  • Huang DCS; Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
  • Kanto T; Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Akira S; Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia.
  • Matsuura Y; The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan.
PLoS Pathog ; 14(9): e1007299, 2018 09.
Article em En | MEDLINE | ID: mdl-30261081
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína bcl-X / Flavivirus Tipo de estudo: Prognostic_studies Idioma: En Revista: PLoS Pathog Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína bcl-X / Flavivirus Tipo de estudo: Prognostic_studies Idioma: En Revista: PLoS Pathog Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão País de publicação: Estados Unidos